Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HJEMMELEGENE BHT AS
AS
Active
Org 929672097
Dronning Eufemias Gate 16, 0191 Oslo
Other human health activities n.e.c. · NACE 8699
Est. 2022
7 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 3M
+122% vs 2023
EBITDA margin
-7.3%
+85% vs 2023
Equity ratio
-229.0%
Financial strength
Net profit 2024
NOK -237K
+84% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
-1M
-100%
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 3M
+122%
EBITDA
NOK -220K
+85%
Net profit
NOK -237K
+84%
Total assets
NOK 729K
-43%
Equity
NOK -1,7M
-17%
Employees
7
—
Company information
Legal name
HJEMMELEGENE BHT AS
Org number
929672097
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
22. august 2022
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Formidling av bedriftshelsetjenester.
Contact
Address
Dronning Eufemias Gate 16, 0191 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
0M
2022
1M
2023
3M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
-1M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
24
1 367
3 035
Staff expenses
−0
−2 585
−2 709
EBITDA
−2
−1 454
−220
Depreciation & amort.
−0
−2
−17
EBIT
−2
−1 456
−237
Net financials
0
0
−0
Profit before tax
−2
−1 456
−237
Tax
−0
−0
−0
Net profit
−2
−1 456
−237
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
54
1 288
729
Equity
23
−1 433
−1 670
Long-term debt
0
0
1 787
Short-term debt
31
2 721
613
Total debt
31
2 721
2 399
Financial ratios
5-year trend
EBITDA margin
-7.3%
This company
15.8%
Market median
-146% vs market
2022
2024
Equity ratio
-229.0%
This company
38.2%
Market median
-699% vs market
2022
2024
Return on equity
-23728700.0%
This company
18.4%
Market median
-128960426% vs market
2022
2024
Net profit margin
-7.8%
This company
8.1%
Market median
-196% vs market
2022
2024
Asset turnover
4.16×
This company
1.12×
Market median
+271% vs market
2022
2024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-06-28 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KJ
Knut Johan Arnholdt
Chief Executive Officer
Chief Executive Officer
2024
Former (1)
ØG
Ørnulf Giffhorn Krüger
Chief Executive Officer
Chief Executive Officer
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RB
Raman Bhatnagar
Chairman
2022
PL
Pål Lillebø
Chairman
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Hjemmelegene As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Hjemmelegene As
HJEMMELEGENE BHT AS
(this company)
Board network connections
Board members of HJEMMELEGENE BHT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Knut Johan Arnholdt
Chief Executive Officer
0 companies
Ørnulf Giffhorn Krüger
Chief Executive Officer
0 companies
Raman Bhatnagar
Chairman
0 companies
Pål Lillebø
Chairman
0 companies